Cryoport, Inc. (CYRX)

Market Cap	311.44M
Revenue (ttm)	228.39M
Net Income (ttm)	-122.76M
Shares Out	49.91M
EPS (ttm)	-2.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	595,013
Open	7.10
Previous Close	7.10
Day's Range	6.21 - 7.12
52-Week Range	4.58 - 20.11
Beta	1.67
Analysts	Strong Buy
Price Target	11.33 (+81.57%)
Earnings Date	Mar 4, 2025

About CYRX

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport Express Cryogenic HV3 Shipping System (HV3); Smartpak II Condition Monitoring System and Tec4Med; Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clini...

• Industry: Integrated Freight & Logistics
• Sector: Industrials
• Founded: 1999
• Employees: 1,105
• Stock Exchange: NASDAQ
• Ticker Symbol: CYRX
• Website: https://www.cryoportinc.com

Financial Performance

In 2024, Cryoport's revenue was $228.39 million, a decrease of -2.09% compared to the previous year's $233.26 million. Losses were -$122.76 million, 14.1% more than in 2023.

Analyst Forecast

According to 6 analysts, the average rating for CYRX stock is "Strong Buy." The 12-month stock price forecast is $11.33, which is an increase of 81.57% from the latest price.

Price Target

$11.33

(81.57% upside)

Analyst Consensus: Strong Buy